197 related articles for article (PubMed ID: 21651906)
1. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.
Kawachi M; Matsunaga Y; Tanaka T; Hori Y; Ito K; Nagahama K; Ozaki T; Inoue N; Toda R; Yoshii K; Hirayama M; Kawabata Y; Takei M
Eur J Pharmacol; 2011 Sep; 666(1-3):218-25. PubMed ID: 21651906
[TBL] [Abstract][Full Text] [Related]
2. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
[TBL] [Abstract][Full Text] [Related]
3. Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach.
Ito K; Kawachi M; Matsunaga Y; Hori Y; Ozaki T; Nagahama K; Hirayama M; Kawabata Y; Shiraishi Y; Takei M; Tanaka T
Drug Res (Stuttg); 2016 Apr; 66(4):196-202. PubMed ID: 26418413
[TBL] [Abstract][Full Text] [Related]
4. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
[TBL] [Abstract][Full Text] [Related]
5. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats.
Seto K; Sasaki T; Katsunuma K; Kobayashi N; Tanaka K; Tack J
Neurogastroenterol Motil; 2008 Sep; 20(9):1051-9. PubMed ID: 18482254
[TBL] [Abstract][Full Text] [Related]
6. Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach.
Yoshii K; Iikura M; Hirayama M; Toda R; Kawabata Y
Pharm Res; 2016 Feb; 33(2):292-300. PubMed ID: 26350104
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo.
Tsubouchi T; Saito T; Mizutani F; Yamauchi T; Iwanaga Y
J Pharmacol Exp Ther; 2003 Aug; 306(2):787-93. PubMed ID: 12724347
[TBL] [Abstract][Full Text] [Related]
8. Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia.
Suzuki H; Hibi T
Neurogastroenterol Motil; 2010 Jun; 22(6):595-9. PubMed ID: 20553562
[TBL] [Abstract][Full Text] [Related]
9. Distribution of acotiamide, an orally active acetylcholinesterase inhibitor, into the myenteric plexus of rat and dog stomachs.
Yoshii K; Yamaguchi T; Hirayama M; Toda R; Kinomoto T; Kawabata Y; Chiba K
Life Sci; 2016 Jan; 145():93-7. PubMed ID: 26682939
[TBL] [Abstract][Full Text] [Related]
10. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.
Tack J; Janssen P
Expert Opin Investig Drugs; 2011 May; 20(5):701-12. PubMed ID: 21417958
[TBL] [Abstract][Full Text] [Related]
11. Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.
Keto Y; Hirata T; Takemoto Y; Yamano M; Yokoyama T
Neurogastroenterol Motil; 2012 Feb; 24(2):147-53, e88. PubMed ID: 22066725
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
[TBL] [Abstract][Full Text] [Related]
13. Acotiamide improves stress-induced impaired gastric accommodation.
Ikeo K; Oshima T; Sei H; Kondo T; Fukui H; Watari J; Miwa H
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27860042
[TBL] [Abstract][Full Text] [Related]
14. Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach.
Yoshii K; Hirayama M; Nakamura T; Toda R; Hasegawa J; Takei M; Mera Y; Kawabata Y
J Pharm Sci; 2011 Nov; 100(11):4965-73. PubMed ID: 21630282
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of alpha2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence.
Fülöp K; Zádori Z; Rónai AZ; Gyires K
Eur J Pharmacol; 2005 Dec; 528(1-3):150-7. PubMed ID: 16313902
[TBL] [Abstract][Full Text] [Related]
16. Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach.
Cellek S; Thangiah R; Jarvie EM; Vivekanandan S; Lalude O; Sanger GJ
Neurogastroenterol Motil; 2008 May; 20(5):539-45. PubMed ID: 18194150
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Uptake Transporter Responsible for Distribution of Acotiamide into Stomach Tissue.
Hirayama M; Hoshino Y; Yoshii K; Toda R; Kawabata Y; Nakanishi T; Tamai I
Mol Pharm; 2020 Apr; 17(4):1071-1078. PubMed ID: 32105080
[TBL] [Abstract][Full Text] [Related]
18. Effect of acotiamide on gastric emptying in healthy adult humans.
Zai H; Matsueda K; Kusano M; Urita Y; Saito Y; Kato H
Eur J Clin Invest; 2014 Dec; 44(12):1215-21. PubMed ID: 25370953
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage.
Matsueda K; Hongo M; Tack J; Aoki H; Saito Y; Kato H
Neurogastroenterol Motil; 2010 Jun; 22(6):618-e173. PubMed ID: 20059698
[TBL] [Abstract][Full Text] [Related]
20. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.
Nakamura K; Tomita T; Oshima T; Asano H; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Ohda Y; Fukui H; Kazuhito F; Hirota S; Watari J; Miwa H
J Gastroenterol; 2017 May; 52(5):602-610. PubMed ID: 27639387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
